OXFORD, England--(BUSINESS WIRE)--British ... smarter development of next-generation biotherapeutics." Michelle Teng, Etcembly CEO Etcembly’s flagship AI platform, EMLy™, stands as the most ...

OXFORD, United Kingdom, Nov. 15, 2024 (GLOBE NEWSWIRE) -- Barinthus Biotherapeutics plc (NASDAQ ... in celiac disease will be prioritized.The pipeline prioritization is expected to result in ...

Bolt Biotherapeutics’ pipeline candidates are built on the Company’s deep expertise in myeloid biology and cancer drug development. The Company’s pipeline includes BDC-3042, a first-in-class ...

Bolt Biotherapeutics’ pipeline candidates are built on the Company’s deep expertise in myeloid biology and cancer drug development. The Company’s pipeline includes BDC-3042, a first-in-class ...

I'm confident in our strategy. Our balance sheet and three streams of revenue will enable the next phase of pipeline development for Protalix BioTherapeutics. We look forward to updating you on ...

Iovance Biotherapeutics (NASDAQ: IOVA) didn't quite end the stock trading week on a high note. The company's shares were dinged by almost 6% that day, due largely to an analyst's recommendation ...

Ratings for Arcutis Biotherapeutics ARQT were provided by 9 analysts in the past three months, showcasing a mix of bullish and bearish perspectives. The following table provides a quick overview ...

Iovance Biotherapeutics faced a challenging week, experiencing a share price decrease of 45% following the release of disappointing Q1 2025 financial results and a significant downward revision of ...

Canada has effectively suspended almost all of its retaliatory tariffs on US products, tamping down inflation risks and improving its growth outlook, according to Oxford Economics. The government ...

THOUSAND OAKS, Calif.--(BUSINESS WIRE)--Atara Biotherapeutics, Inc. (Nasdaq: ATRA), a leader in T-cell immunotherapy, leveraging its novel allogeneic Epstein-Barr virus (EBV) T-cell platform to ...